Clonal hematopoiesis of indeterminate potential

Clonal hematopoiesis of indeterminate potential has been studied in 6 papers since 2023: 6 observational studies in people; 4 in the past year. The newest paper, Aug 31, 2026: “Age-related clonal hematopoiesis and mosaic sex chromosome loss define distinct systemic proteomic programs and disease vulnerabilities”.

Exposure

6 papers study it13 findingsUpdated

See all 6 papers on clonal hematopoiesis of indeterminate potential

At a glance

The findings reach people, from one lab or study. 4 independent labs in 4 countries.

“non-DNMT3A CHIP was associated with broad multisystem disease burden”
Age-related clonal hematopoiesis and mosaic sex chromosome loss define distinct systemic proteomic programs and disease vulnerabilitiesmedRxiv2026doi:10.64898/2026.08.29.26361722

1 of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 4 independent labs in 4 countries
  • 1 finding against
  • Funders: National Institutes of Health and others
  • Humans6

What did studies of clonal hematopoiesis of indeterminate potential find?

1

Studies of clonal hematopoiesis of indeterminate potential measured one outcome, myocardial fibrosis.

Myocardial fibrosis

upin humans1OR 1.31

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with higher myocardial fibrosis in humans (OR 1.31 (95% CI 1.07-1.59) for top quintile).

    “Large CHIP was associated with 1.31-fold odds (95% CI 1.07-1.59; P = .009) of being in the top quintile of myocardial fibrosis by CMR.”

    Humansheartvariant allele fraction ≥10%n = 9,191

    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias

    European heart journal

More on Myocardial fibrosis

What is clonal hematopoiesis of indeterminate potential linked with?

11

Studies link clonal hematopoiesis of indeterminate potential with 11 measures, among them intracerebral hemorrhage, myeloid immune regulation and multisystem diseases.

Intracerebral hemorrhage

downin humans1upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a lower risk of intracerebral hemorrhage in humans (JAK2 subtype).

    “JAK2-CHIP exhibited inverse associations with intracerebral hemorrhage and atrial fibrillation”

    HumansJAK2 subtype

    Subtype-specific effects of clonal hematopoiesis on cerebrovascular and cardiometabolic disease risk

    Frontiers in neurology

  2. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of intracerebral hemorrhage in humans (ASXL1 subtype).

    “ASXL1-CHIP also showed directional risk elevations for intracerebral hemorrhage and hypertension.”

    HumansASXL1 subtype

    Subtype-specific effects of clonal hematopoiesis on cerebrovascular and cardiometabolic disease risk

    Frontiers in neurology

More on Intracerebral hemorrhage

myeloid immune regulation

upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential is associated with myeloid immune regulation in humans.

    “non-DNMT3A CHIP to myeloid immune regulation”

    Humansnon-DNMT3A

    Age-related clonal hematopoiesis and mosaic sex chromosome loss define distinct systemic proteomic programs and disease vulnerabilities

    medRxivPreprint

Multisystem diseases

upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential is associated with multisystem diseases in humans.

    “non-DNMT3A CHIP was associated with broad multisystem disease burden”

    Humansnon-DNMT3A

    Age-related clonal hematopoiesis and mosaic sex chromosome loss define distinct systemic proteomic programs and disease vulnerabilities

    medRxivPreprint

More on Multisystem diseases

Kidney failure

upin humans1HR 1.9

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of kidney failure in patients with CKD, KNOW-CKD cohort, multivariable Cox regression (adjusted HR 1.90 (95% CI 1.03 to 3.51)).

    “CHIP was associated with higher risk of KF (adjusted hazard ratio, 1.90; 95% confidence interval, 1.03 to 3.51)”

    Humansin patients with CKD, KNOW-CKD cohort, multivariable Cox regressionmedian follow-up 10.0 years

    Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in CKD: An East Asian Cohort Study

    Clinical journal of the American Society of Nephrology : CJASN

More on Kidney failure

Atrial fibrillation

upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of atrial fibrillation in humans (DNMT3A subtype).

    “DNMT3A-CHIP was positively associated with atrial fibrillation”

    HumansDNMT3A subtype

    Subtype-specific effects of clonal hematopoiesis on cerebrovascular and cardiometabolic disease risk

    Frontiers in neurology

More on Atrial fibrillation

Ischemic stroke

upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential is associated with ischemic stroke in humans (TET2 subtype).

    “TET2-CHIP showed the clearest cerebrovascular signal, with significant associations with ischemic stroke, intracerebral hemorrhage, and hypertension.”

    HumansTET2 subtype

    Subtype-specific effects of clonal hematopoiesis on cerebrovascular and cardiometabolic disease risk

    Frontiers in neurology

More on Ischemic stroke

Cardiac arrhythmia

upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of cardiac arrhythmia in humans (driven by non-DNMT3A driver genes).

    “Gene-specific analyses revealed an increased risk of arrhythmias across driver genes other than DNMT3A.”

    Humansdriven by non-DNMT3A driver genes

    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias

    European heart journal

More on Cardiac arrhythmia

Ventricular arrhythmia

upin humans1HR 1.16

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of ventricular arrhythmia in humans (HR 1.16 (95% CI 1.00-1.34); large CHIP HR 1.22 (95% CI 1.03-1.45)).

    “1.16 (95% CI, 1.00-1.34; P = .049) and 1.22 (95% CI 1.03-1.45; P = .021) for ventricular arrhythmias”

    Humansvariant allele fraction ≥2%

    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias

    European heart journal

More on Ventricular arrhythmia

Bradyarrhythmia

upin humans1HR 1.09

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of bradyarrhythmia in humans (HR 1.09 (95% CI 1.01-1.19); large CHIP HR 1.13 (95% CI 1.03-1.25)).

    “1.09 (95% CI 1.01-1.19; P = .031) and 1.13 (95% CI 1.03-1.25; P = .011) for bradyarrhythmias”

    Humansvariant allele fraction ≥2%

    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias

    European heart journal

More on Bradyarrhythmia

Supraventricular arrhythmia

upin humans1HR 1.11

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of supraventricular arrhythmia in humans (HR 1.11 (95% CI 1.04-1.18); large CHIP HR 1.13 (95% CI 1.05-1.22)).

    “Any and large CHIP were associated with multi-variable-adjusted hazard ratios of 1.11 [95% confidence interval (CI) 1.04-1.18; P = .001] and 1.13 (95% CI 1.05-1.22; P = .001) for supraventricular arrhythmias”

    Humansvariant allele fraction ≥2%n = 13,892

    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias

    European heart journal

More on Supraventricular arrhythmia

All 11

Funding

1 grant since 2026

National Heart, Lung, and Blood Institute$55.1K

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 2Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 04 papers in 12 months